Symbols

EQRX(Delisted)

EQRx·NASDAQ

--(--)

Key Stats

0.0000DAY`S RANGE0.0000

0.000052 WK RANGE0.0000

Open

0.0000

Prev.Close

0.0000

%Range

Turnover

Avg Vol(4W)

Market Cap

Div.Yield

P/E(TTM)

EPS(TTM)

Beta

Free Float

Shares Outstanding

%Turnover

P/E(DYN)

P/B

BVPS

High

0.0000

Low

0.0000

52 Week High

0.0000

52 Week Low

0.0000

About EQRX

Eqrx, Inc.

A pharmaceutical company that developing wide range of medicines for late-stage cancer

Industry

Established Date

01/25/2021

Listing Date

06/03/2021

Exchange

NASDAQ Stock Exchange

Full-time Employees

362

Fiscal Year Ends

12-31

Website

www.eqrx.com

Security Type

Common stock

Office address

50 Hampshire Street, Cambridge, Massachusetts 02139

Business

Introduction

EQRx, Inc., incorporated in Delaware on January 25, 2021, is a company whose mission is to improve the health of all people through high-quality, innovative, affordable medicines. Their "New Pharma" solution starts with mass assembly of drug catalogs, targeting some of the most innovative clinical opportunities and highest drug cost categories today and in the future, initially focusing on oncology and immune inflammatory diseases.

Company Financials

EPS

EQRX has released its 2023 Q1 earnings. EPS was reported at -0.17, versus the expected -0.15, missing expectations. The chart below visualizes how EQRX has performed over recent quarters, highlighting trends in earnings surprises.